A SPRINT to the finish, or just the beginning? Implications of the SPRINT results for nephrologists

Kidney International
Michael V Rocco, Alfred K Cheung

Abstract

The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated a significant reduction in major cardiovascular events and all-cause mortality with intensive blood pressure control in older individuals at high cardiovascular risk, including patients with chronic kidney disease and mild proteinuria. Nephrologists should consider the SPRINT results when determining the optimal blood pressure target for patients with chronic kidney disease.

References

Jun 7, 2014·Clinical Trials : Journal of the Society for Clinical Trials·Walter T AmbrosiusUNKNOWN SPRINT Study Research Group
Nov 10, 2015·The New England Journal of Medicine·UNKNOWN SPRINT Research GroupWalter T Ambrosius

❮ Previous
Next ❯

Citations

Aug 16, 2016·Kidney International·Christina M Wyatt, Glenn M Chertow
Sep 12, 2018·JAAPA : Official Journal of the American Academy of Physician Assistants·Kim Zuber, Jane Davis
May 20, 2017·Clinical Journal of the American Society of Nephrology : CJASN·Radica Z AlicicKatherine R Tuttle
Nov 23, 2021·Antioxidants & Redox Signaling·Sih Min TanMelinda T Coughlan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.